SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Proteonomix, Inc. (PROT) Announces Its Clinical Trial of UMK-121 in Patients With End Stage Liver Disease Has Been Listed on ClinicalTrials.gov